Thomas Delate

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Venues

Journal of thrombosis and thrombolysis

Pharmacy practice

JCO oncology practice

The Permanente journal

University of Arizona (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Arizona Aug 01 1997 - Feb 28 2002

United States

PHD :: Pharmaceutical Sciences

Publications

Ye Ji Lee, Thomas Delate, Rita L Hui, Kim Le, Catherine Pham
Real-World Noninferiority Assessment of Two Filgrastim Biosimilars in Patients Receiving Myelosuppressive Chemotherapy. JCO oncology practice (2024)
Olivia M Kim, Tatyana K Givens, Emily G Tang, Jennifer J Schimmer, Tanya Ramsey, Kayla Boyd, Thomas Delate
Real-World Outcomes of Proprotein Convertase Subtilisin Kexin-9 Inhibitors Use. Journal of cardiovascular pharmacology (2023)
Angie A Suh, Paul B Shaw, Mark Y Jeong, Kari L Olson, Thomas Delate
Transthyretin Amyloid Cardiomyopathy Risk Evaluation in a Cohort of Patients With Heart Failure. The Permanente journal (2023)
Catherine Pham, Fang Niu, Rita L Hui, Kim N Le, Thomas Delate
Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto. Clinical rheumatology (2023)
Lauren Cline, Erika Marie G Generoso, Nicholas D'Apice, Sara K Dellinger, Amber Tovey, Nathan P Clark, Fang Nui, Rita Hui, Stephanie A Hale, Tanya Ramsey, Kimi Pontoppidan, Hasmig Ekmekdjian, Kristen Fink, Daniel M Witt, Mark A Crowther, Thomas Delate
Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min. Journal of thrombosis and thrombolysis 55 (2) (2022)
Lauren Cline, Erika Marie G Generoso, Nicholas D'Apice, Sara K Dellinger, Amber Tovey, Nathan P Clark, Fang Nui, Rita Hui, Stephanie A Hale, Tanya Ramsey, Kimi Pontoppidan, Hasmig Ekmekdjian, Kristen Fink, Daniel M Witt, Mark A Crowther, Thomas Delate
Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min. Journal of thrombosis and thrombolysis (2022)
Lauren Cline, Erika Marie G Generoso, Nicholas D'Apice, Sara K Dellinger, Amber Tovey, Nathan P Clark, Fang Nui, Rita Hui, Stephanie A Hale, Tanya Ramsey, Kimi Pontoppidan, Hasmig Ekmekdjian, Kristen Fink, Daniel M Witt, Mark A Crowther, Thomas Delate
Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min. Journal of thrombosis and thrombolysis 55 (2) (2022)
Hanifah Davis, Rachel Heilmann, Jessica Milchak, Thomas Delate
Factors associated with A1C reduction with GLP-1 agonist or SGLT-2 inhibitor use. Family practice 38 (5) (2021)
Catherine G Derington, Nancy Benavides, Thomas Delate, Douglas N Fish
Multiple-Dose Oral Fosfomycin for Treatment of Complicated Urinary Tract Infections in the Outpatient Setting. Open forum infectious diseases 7 (2) (2020)
Catherine G Derington, Lauren J Heath, David P Kao, Thomas Delate
Validation of algorithms to identify elective percutaneous coronary interventions in administrative databases. PloS one 15 (4) (2020)
Georgina S Farrow, Thomas Delate, Kelsey McNeil, Aubrey E Jones, Daniel M Witt, Mark A Crowther, Nathan P Clark
Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10. Journal of thrombosis and haemostasis : JTH 18 (5) (2020)
Jared Freml, Thomas Delate, Jesus Hermosillo-Rodriguez
Guideline-recommended incorporation of biomarker testing results in metastatic colorectal cancer therapy. Personalized medicine 17 (3) (2020)
Michele Wood, Thomas Delate, Sheila L Stadler, Anne M Denham, Leslie K Ruppe, Roseanne Hornak, Kari L Olson
Trends in high intensity statin use among secondary prevention patients 76 years and older. Pharmacy practice 17 (2) (2019)
Jason Chau, Thomas Delate, Taylor Ota, Bharati Bhardwaja
Patient Perspectives on Switching from Infliximab to Infliximab-dyyb in Patients with Rheumatologic Diseases in the United States. ACR open rheumatology 1 (1) (2019)
Lisa A Thompson, Lauren J Heath, Heather Freml, Thomas Delate
Universal hepatitis B screening and management in patients with cancer who received immunosuppressive chemotherapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2019)
Yardlee S Kauffman, Thomas Delate, Sheila Botts
Metabolic monitoring in children 5 years of age and younger prescribed second-generation antipsychotic medications. The mental health clinician 7 (1) (2018)
Samuel G Johnson, Paul B Shaw, Thomas Delate, Deanna L Kurz, Dylon Gregg, John C Darnell, Christina L Aquilante
Feasibility of clinical pharmacist-led CYP2C19 genotyping for patients receiving non-emergent cardiac catheterization in an integrated health system. Pharmacy practice 15 (2) (2017)
Thomas Delate, Steven Wang
Assessment of the rates and characteristics of the short-term supply of medication (Tider) from an integrated healthcare delivery system in the United States. Pharmacy practice 15 (2) (2017)

Thomas Delate.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Delate